Evaluation of a primary treatment algorithm using combination therapy for the management of patients with hypertension and hypercholesterolemia

Trial Profile

Evaluation of a primary treatment algorithm using combination therapy for the management of patients with hypertension and hypercholesterolemia

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jun 2012

At a glance

  • Drugs ACE inhibitors; Alpha adrenergic receptor antagonists; Amlodipine/atorvastatin; Angiotensin receptor antagonists; Beta-adrenergic receptor antagonists; Calcium channel antagonists; Diuretics; Ezetimibe; Spironolactone
  • Indications Hypercholesterolaemia; Hypertension
  • Focus Therapeutic Use
  • Acronyms STITCH2
  • Most Recent Events

    • 13 Jun 2012 Additional lead trial centre (University of Western Ontario) identified as reported by ClinicalTrials.gov.
    • 13 Jun 2012 Actual patient number is 1000 according to ClinicalTrials.gov.
    • 13 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top